The African component of the project focuses on integrating a mobile-health intervention into existing cardiovascular and INR monitoring pathways to improve Time in Therapeutic Range (TTR) and reduce morbidity among individuals with RHD-associated atrial fibrillation.
Prof. Liesl Zühlke, MBChB, DCH, FCPaeds, Cert Card, MPH, PHD, MSc (South African Medical Research Council)
Prof. Mark Engel, BSc(MED)Hons, MPH, PhD (South African Medical Research Council)
Prof. Mpiko Ntsekhe, MD, PhD (University of Cape Town)